by Alex Kadhim
New research identifies NLRP6 as a critical regulator of donor T-cell activity after allogeneic hematopoietic cell transplantation, showing that loss of NLRP6 worsens acute graft-versus-host...
by Alex Kadhim
New research identifies donor-cell GATA3 as a key driver of intestinal graft-versus-host disease after hematopoietic cell transplantation, linking it to pathogenic T-cell activity, tissue damage,...
by Alex Kadhim
Published in Blood Advances, researchers from the MIDAS consortium, including Roswell Park Comprehensive Cancer Center, The Ohio State University, Cincinnati Children’s Medical Center, and...
by Alex Kadhim
Researchers at The University of Texas MD Anderson Cancer Center have demonstrated that permissive human leukocyte antigen (HLA)-DPB1 mismatches can reduce relapse after matched unrelated donor...
by ASTCT Talks
In a cobranded episode between Oncology on the Go, hosted by CancerNetwork®, and the American Society for Transplantation and Cellular Therapy (ASTCT)’s program ASTCT Talks,...
by ASTCT Talks
In this episode of ASTCT Talks, host Dr. Corey Cutler, MD, from Dana-Farber Cancer Institute, is joined by Dr. Pooja Khandelwal, MD (Cincinnati Children’s Hospital), Dr. Ben...